BioCentury | Mar 31, 2021
Finance

March 31 Quick Takes: Muted reception for Achilles in market debut; plus BridgeBio-Helsinn, Scribe, Outpace, OnQuality, AffaMed, Treos

...enter the clinic over the next 18 months.AffaMed unveils first deal since series BAffaMed Therapeutics and SIFI...
...more than $170 million in a series B round Tuesday, will fund the venture, with SIFI...
...Bio Ltd. OncoResponse Inc. BridgeBio Pharma Inc. Helsinn Group AffaMed Therapeutics (Shanghai) Co. Ltd. Helsinn Healthcare S.A. Achilles Therapeutics Ltd. Outpace Bio Inc. SIFI...
BioCentury | Mar 31, 2021
Emerging Company Profile

Mega-round meets dealmaker as CBC’s AffaMed readies to build pipeline

...announcement when it unveiled a JV with SIFI...
...Kong. AffaMed will fund the venture, with SIFI...
...Ltd., Ocular Therapeutix Inc., Samsung Bioepis Co. Ltd., SIFI...
BioCentury | Jan 29, 2020
Company News

Jan. 28 Company Quick Takes: Kite, Alkermes, Regeneron-Sanofi, Incyte, NantHealth-NantOmics, Sorrento, MicroCures, Paion-Mundipharma

Kite’s KTE-X19 under review in Europe EMA has accepted an MAA for KTE-X19 from Kite, positioning the CAR T cell therapy from the Gilead Sciences Inc. (NASDAQ:GILD) unit to become the first CAR T cell...
BioCentury | Mar 31, 2014
Company News

NovaMedica, Societa Industria Farmaceutica Italiana S.p.A sales and marketing update

...Societa Industria Farmaceutica Italiana (SIFI) granted NovaMedica exclusive rights to commercialize eight ophthalmic products in the...
...year. The products are approved in Russia and the EU. NovaMedica declined to disclose details. SIFI...
BioCentury | Jan 14, 2008
Clinical News

Polihexanide regulatory update

The EC granted Orphan Drug designation for polihexanide, an antibacterial agent to treat Acanthamoeba keratitis. Società Industria Farmaceutica Italiana S.p.A. , Rome, Italy Product: Polihexanide Business: Infectious WIR Staff Infectious...
BioCentury | Jul 12, 1993
Company News

Bio-Technology General sales and marketing update

...the shape of the eye during surgery, BTGC said. Ophtapharma is a joint venture of Societa Industria Farmaceutica Italiana S.p.A....
Items per page:
1 - 6 of 6
BioCentury | Mar 31, 2021
Finance

March 31 Quick Takes: Muted reception for Achilles in market debut; plus BridgeBio-Helsinn, Scribe, Outpace, OnQuality, AffaMed, Treos

...enter the clinic over the next 18 months.AffaMed unveils first deal since series BAffaMed Therapeutics and SIFI...
...more than $170 million in a series B round Tuesday, will fund the venture, with SIFI...
...Bio Ltd. OncoResponse Inc. BridgeBio Pharma Inc. Helsinn Group AffaMed Therapeutics (Shanghai) Co. Ltd. Helsinn Healthcare S.A. Achilles Therapeutics Ltd. Outpace Bio Inc. SIFI...
BioCentury | Mar 31, 2021
Emerging Company Profile

Mega-round meets dealmaker as CBC’s AffaMed readies to build pipeline

...announcement when it unveiled a JV with SIFI...
...Kong. AffaMed will fund the venture, with SIFI...
...Ltd., Ocular Therapeutix Inc., Samsung Bioepis Co. Ltd., SIFI...
BioCentury | Jan 29, 2020
Company News

Jan. 28 Company Quick Takes: Kite, Alkermes, Regeneron-Sanofi, Incyte, NantHealth-NantOmics, Sorrento, MicroCures, Paion-Mundipharma

Kite’s KTE-X19 under review in Europe EMA has accepted an MAA for KTE-X19 from Kite, positioning the CAR T cell therapy from the Gilead Sciences Inc. (NASDAQ:GILD) unit to become the first CAR T cell...
BioCentury | Mar 31, 2014
Company News

NovaMedica, Societa Industria Farmaceutica Italiana S.p.A sales and marketing update

...Societa Industria Farmaceutica Italiana (SIFI) granted NovaMedica exclusive rights to commercialize eight ophthalmic products in the...
...year. The products are approved in Russia and the EU. NovaMedica declined to disclose details. SIFI...
BioCentury | Jan 14, 2008
Clinical News

Polihexanide regulatory update

The EC granted Orphan Drug designation for polihexanide, an antibacterial agent to treat Acanthamoeba keratitis. Società Industria Farmaceutica Italiana S.p.A. , Rome, Italy Product: Polihexanide Business: Infectious WIR Staff Infectious...
BioCentury | Jul 12, 1993
Company News

Bio-Technology General sales and marketing update

...the shape of the eye during surgery, BTGC said. Ophtapharma is a joint venture of Societa Industria Farmaceutica Italiana S.p.A....
Items per page:
1 - 6 of 6